The Pharma Data

OCTOBER 19, 2020

DB ( Becton, Dickinson and Company ) received a CE mark for its BD Multitest 6-Color TBNK Reagent with BD Trucount Tubes for assessing immune function in COVID-19 patients. In a challenge trial, people are given a vaccine then intentionally dosed with the virus or bacteria that causes the disease. Please read more here. .

Vaccination 52

Vaccination Vaccine Trials Clinical Trials 52

The Pharma Data

DECEMBER 23, 2020

The agreement includes a £500,000 upfront payment to Avacta which gives Astrea the rights to generate and develop Affimer reagents in-house for affinity separation. Astrea is a leading provider of affinity separation solutions to the pharmaceutical and biomanufacturing industries. It is a division of Gamma Biosciences.

Drugs 52

Drugs Licensing Licensing Vaccination 52

Roots Analysis

OCTOBER 16, 2023

DNA cloning is a largely accepted technique, however, it has been regulated carefully. Further, the labor and reagent cost incurred in cloning procedures is reduced with customized cloning. Further, there are ethical issues as well, along with reproductive and mutation challenges as well associated with DNA cloning and gene cloning.

DNA 40

DNA Gene Protein In-Vitro 40